Billionaires Holding RPRX

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 24.3M
    Shares Outstanding

  • 40.85M
    Market Cap

News & Insights

ABOUT

RPRX

Repros Therapeutics Inc., a development stage biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders in the United States. Its product portfolio includes Androxal, an oral therapy, which is in Phase III clinical trials for the treatm...

Google parent Alphabet's earnings: $8.42 per share, vs expected EPS of $8.04

NEWS

Amazon keeps its crown as king of cloud as sales pop

READ MORE